勘误：身体组成对转移性结直肠癌预后和剂量限制毒性的影响
Corrigendum: Impact of body composition on prognosis and dose-limiting toxicities on metastatic colorectal cancer.
作者信息
da Silva Dias David, Machado Mafalda, Trabulo Carolina, Gosálbez Beatriz, Ravasco Paula
机构信息
Medical Oncology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal.
Centre for Interdisciplinary Research in Health, Universidade Católica Portuguesa, Lisbon, Portugal.
出版信息
Front Nutr. 2023 Jul 25;10:1252840. doi: 10.3389/fnut.2023.1252840. eCollection 2023.
Abstract
[This corrects the article DOI: 10.3389/fnut.2021.671547.].
摘要
[本文更正了文章DOI：10.3389/fnut.2021.671547。]
相似文献
1
Corrigendum: Impact of body composition on prognosis and dose-limiting toxicities on metastatic colorectal cancer.勘误：身体组成对转移性结直肠癌预后和剂量限制毒性的影响
Front Nutr. 2023 Jul 25;10:1252840. doi: 10.3389/fnut.2023.1252840. eCollection 2023.
2
Impact of Body Composition on Prognosis and Dose-Limiting Toxicities on Metastatic Colorectal Cancer.身体组成对转移性结直肠癌预后及剂量限制性毒性的影响
Front Nutr. 2022 Jan 27;8:671547. doi: 10.3389/fnut.2021.671547. eCollection 2021.
3
Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study.肌肉减少症在转移性结直肠癌患者一线化疗期间的预后作用：一项回顾性研究。
World J Clin Oncol. 2021 May 24;12(5):355-366. doi: 10.5306/wjco.v12.i5.355.
4
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.骨骼肌减少症和全身炎症与转移性肾细胞癌细胞减灭性肾切除术后生存率降低有关。
Cancer. 2022 Jun 1;128(11):2073-2084. doi: 10.1002/cncr.34174. Epub 2022 Mar 14.
5
Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib.接受regorafenib 的转移性结直肠癌患者中肌肉减少症与剂量限制毒性之间的关系。
Clin Transl Oncol. 2019 Nov;21(11):1518-1523. doi: 10.1007/s12094-019-02080-4. Epub 2019 Mar 13.
6
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study.化疗期间的骨骼肌损失及其与转移性结直肠癌的生存和全身治疗毒性的关系：一项 AGEO 前瞻性多中心研究。
Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101603. doi: 10.1016/j.clinre.2020.101603. Epub 2021 Mar 2.
7
The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.肌肉减少症和肌脂肪变性对不可切除胰腺癌或远端胆管癌预后的影响。
Clin Nutr. 2016 Oct;35(5):1103-9. doi: 10.1016/j.clnu.2015.08.005. Epub 2015 Sep 1.
8
Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.多西他赛治疗的转移性去势抵抗性前列腺癌患者身体成分参数对临床结局的影响
Clin Nutr ESPEN. 2016 Jun;13:e39-e45. doi: 10.1016/j.clnesp.2016.04.001. Epub 2016 May 6.
9
Corrigendum: Age-specific reference values for low psoas muscle index at the L3 vertebra level in healthy populations: A multicenter study.勘误：健康人群中L3椎体水平低腰大肌指数的年龄特异性参考值：一项多中心研究。
Front Nutr. 2023 Jan 24;10:1138289. doi: 10.3389/fnut.2023.1138289. eCollection 2023.
10
Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.全身炎症与肌肉减少症与非转移性结直肠癌患者生存的相关性：来自 C SCANS 研究的结果。
JAMA Oncol. 2017 Dec 1;3(12):e172319. doi: 10.1001/jamaoncol.2017.2319.
引用本文的文献
1
Patient-Reported Outcomes and Body Composition Changes in Patients With Colorectal Cancer During Chemotherapy: A Longitudinal Study.化疗期间结直肠癌患者的患者报告结局与身体成分变化：一项纵向研究
J Nurs Manag. 2025 Aug 24;2025:1268096. doi: 10.1155/jonm/1268096. eCollection 2025.
Zotero 插件